Pfizer Inc
Top Portfolio Positions
16 positions ·
$297,050,684 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
8,223,341 | $104,189,729 | 35.07% | |
| ALLO |
Allogene Therapeutics, Inc.
Healthcare
|
22,032,040 | $53,758,177 | 18.10% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
3,457,815 | $36,652,839 | 12.34% | |
| CELC |
Celcuity Inc.
Healthcare
|
295,652 | $33,745,719 | 11.36% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
2,838,913 | $16,891,532 | 5.69% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
1,875,000 | $13,593,750 | 4.58% | |
| PYXS |
Pyxis Oncology, Inc.
Healthcare
|
7,032,770 | $10,267,843 | 3.46% | |
| CRBU |
Caribou Biosciences, Inc.
Healthcare
|
4,690,431 | $8,911,818 | 3.00% | |
| SPRO |
Spero Therapeutics, Inc.
Healthcare
|
2,362,348 | $5,527,894 | 1.86% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
505,645 | $4,277,756 | 1.44% |
Portfolio Trend
6 quarters · across all stocks
Holdings in ARVN
Shares Held
Position Value (USD)
6 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,652,839 | 3,457,815 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $41,009,685 | 3,457,815 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $29,460,583 | 3,457,815 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $25,449,518 | 3,457,815 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $24,273,861 | 3,457,815 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $66,286,313 | 3,457,815 | Shares | Sole | 2025-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||